Skip to content
type1.science

Instinct sensor (made by Abbott, sold by MiniMed)

Abbott (manufactured) / MiniMed (sold)

What it is

An Abbott-built, MiniMed-sold CGM with up to 15 days of wear. Manufacturer-documented US configurations include MiniMed 780G, MiniMed Go and MiniMed Flex. A randomized crossover study reported noninferior 780G time in range versus Simplera Sync; this does not establish an accuracy ranking against Guardian 4 or standalone Simplera.

Editorial review: .

Most recent recorded citation date: 2026-09-01. Only explicit date metadata is included; an undated citation may be newer. This does not mean every claim was reviewed on that date.

Trial status, labels and access can change between reviews. How we review the evidence · How to read the evidence

Full sources ↓Full discussion ↓Report an issue →

Available nowRegulator-approvedcgm

Evidence behind this assessment

Key evidence notes. Study results, product eligibility and access answer different questions.

Who was studied?
Study populations and analysis groups vary. Product age limits alone do not describe who was studied.
Benefit or performance
Accuracy: The original crossover abstract reports 780G glycemic outcomes with Instinct and Simplera Sync, rather than reference-method MARD. It does not establish analytical accuracy superiority over Guardian 4, standalone Simplera or Dexcom sensors. This score remains an editorial judgment, not a validated cross-device accuracy ranking.[6]
Important harms and treatment burden
Read the safety discussion and original sources. A missing summary does not establish safety.
Approval and country access
Country-specific approval and access are not summarized in this record.Approval, trial recruitment, local supply and funding are separate. Check the cited label or access source.
Follow-up and remaining uncertainty
Read the full discussion and original sources for follow-up duration and study limitations.

This record cites company or conference reports. Those sources may describe interim findings; their source type is shown in the source list.

Editorial score: calculation and evidence

A weighted editorial judgment on a 0–100 scale, not a probability of success or a measured treatment effect. Higher criterion scores mean more favorable assessments.

Default calculation: 80 × 20 + 65 × 15 + 35 × 15 + 88 × 10 + 90 × 10 + 75 × 10 + 88 × 10 + 0 × 5 + 55 × 5 = 6785; divide by total weight 100. Unrounded weighted result: 67.85.

Accuracy80

The original crossover abstract reports 780G glycemic outcomes with Instinct and Simplera Sync, rather than reference-method MARD. It does not establish analytical accuracy superiority over Guardian 4, standalone Simplera or Dexcom sensors. This score remains an editorial judgment, not a validated cross-device accuracy ranking.[6]

Low lag65

It reads interstitial fluid like every other sensor here, so the ~10–15 minute physiological lag behind blood glucose is unchanged. No Instinct-specific lag data have been published; this is not a differentiator either way.

Interoperability35

Manufacturer-documented US configurations include MiniMed 780G, MiniMed Go and MiniMed Flex with Instinct. These are specific system pairings; this criterion does not establish compatibility with every other pump, app or open-source system.[10]

Sensor lifespan88

Up to 15 days of wear — double MiniMed's own Guardian 4 and Simplera Sync (7 days and 6–7 days), and matching the longest-wearing sensors available.[4]

No calibration90

Factory-calibrated — no routine fingersticks required.[7]

Alerts & prediction75

Configurable high/low alerts through the MiniMed app, with 5-minute readings; in the MiniMed Go smart-pen system the alerts also drive missed-dose and high-glucose dosing prompts. No published head-to-head of its hypo-detection rate, so scored at the category norm rather than above it.[3]

Form factor88

A one-piece disposable sensor with no separate transmitter, marketed as the smallest and thinnest integrated CGM, with a 1-hour warm-up — faster than Simplera's 2 hours.[7]

Ketone sensing0

No ketone sensing — glucose only. Abbott's ketone work sits in its separate Libre line, not here.

Access & cost55

Genuinely purchasable on two continents — US ordering opened September 2025 with the full commercial launch in December 2025, and the EU followed with a CE Mark in March 2026 and a country-by-country rollout from June 2026. But it is only obtainable if you are already on MiniMed hardware, which is the whole limitation.[5]

Editor’s take

Instinct adds an Abbott-made sensor option for the MiniMed 780G. The current US manufacturer page lists it alongside Simplera Sync and Guardian 4; changing sensors may require a pump-software update. This provides a choice of compatible sensors, without establishing that one is clinically superior.

The full picture

The Instinct sensor is the sensor Abbott makes and MiniMed sells. It is a one-piece, disposable, factory-calibrated continuous glucose monitor (CGM) worn on the upper arm, with up to 15 days of wear, a 1-hour warm-up, and a reading every five minutes.7

What it works with — read this before anything else. Instinct is not a consumer product you can just buy. It exists only inside MiniMed's ecosystem: the MiniMed 780G closed loop, cleared by the FDA on 2 September 2025 (which also cleared MiniMed's SmartGuard algorithm as an interoperable automated glycemic controller, or iAGC);1 the MiniMed Go smart-pen system for people on injections, cleared on 12 January 2026, which pairs the InPen with Instinct in a single app;3 and, from 17 August 2026, MiniMed Flex, which MiniMed says is commercially shipping in the US with Instinct as well as Simplera Sync.10 It does not work with Tandem, Omnipod, iLet, or any open-source loop. And although Abbott builds it, it is not a FreeStyle Libre — it does not work with Libre's apps or readers. If you are not on MiniMed hardware, this sensor is not available to you at any price.

Accuracy — useful system evidence, not standalone accuracy validation. The American Diabetes Association's Consumer Guide lists Instinct's MARD (mean absolute relative difference — lower is better) at 8.2%.7 A peer-reviewed randomized crossover study is now available: 23 adults with T1D completed six weeks on each sensor, with mean time in range of 80.6% on Simplera Sync and 79.1% on Instinct; Instinct met the prespecified noninferiority criterion for 780G glycemic outcomes.6

That result answers a narrower question than MARD. The study did not compare Instinct readings against a reference method, did not report standalone sensor MARD, and included MiniMed-affiliated authors. It therefore supports similar short-term 780G outcomes when switching sensors, but it does not independently validate the advertised 8.2% accuracy figure. A manufacturer- independent analytical head-to-head remains missing.6

Wear and calibration. Up to 15 days per sensor — double the 7 days of MiniMed's Guardian 4 and the 6–7 days of Simplera Sync, and matching the longest-wearing sensors available.4 It is factory-calibrated, so no routine fingersticks, and it warms up in about an hour.7 Fewer insertions and fewer fingersticks is a real quality-of-life gain, and for a pump user it is the most tangible thing Instinct changes day to day.

Ketones. None. Instinct senses glucose only. Abbott's continuous-ketone work lives in its separate Libre line and is not part of this sensor.

Who it's for — the age rules differ by system and by continent. In the US, the 780G-with-Instinct pairing is cleared from age 7 and up; the MiniMed Go smart-pen system extends down to ages 2–6 with adult supervision.3 In the EU, the CE Mark covers ages 2 and up, and — unlike the US label — explicitly includes pregnancy.4 If you are pregnant and in the US, that indication does not apply to you.

Access. US ordering opened in September 2025 and the full US commercial launch of the 780G with Instinct followed on 2 December 2025.2 Europe got the CE Mark on 10 March 2026,4 with a country-by-country commercial rollout of Instinct and Instinct Go beginning 23 June 2026.5 MiniMed Flex began shipping in the US with Instinct on 17 August 2026.10 So it is genuinely purchasable on two continents — but, again, only as part of MiniMed's system.

The July recall is a pump-software issue, not an Instinct recall. FDA's open Class II record covers 778 international 780G pumps on software 6.62 that can stop insulin after Errors 53 and 23 when paired with Instinct. The correction is to update affected pumps to 6.63. Instinct sensors themselves are not the recalled product.8

What's coming. The European rollout continues market by market through 2026. MiniMed Go is no longer merely expected: it launched in the US in the week of 25 May 2026 and MiniMed's current product pages list the Go configuration.11 The thing worth watching for is a manufacturer-independent, reference-method accuracy study. The published crossover now supports similar 780G glycemic outcomes, but Instinct's headline MARD remains analytically unaudited.

September access check. MiniMed’s 1 September 2026 update confirms European commercial launch of the 780G with Instinct and MiniMed Go with Instinct Go. Product configurations and eligibility remain region-specific.9

What's next for this

  • →Phased country-by-country European rollout of Instinct and Instinct Go continues · 2026
  • →Continued commercial expansion of the launched MiniMed Go system · ongoing

Sources

  1. [1]
    FDA Clears MiniMed 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes · Manufacturer · 2025-09-02 — FDA clearance (2 Sep 2025) of the MiniMed 780G to run on the Abbott-built Instinct sensor, via clearance of SmartGuard as an interoperable automated glycemic controller (iAGC). Confirms up to 15-day wear.

    Medtronic. FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes (Sep 2, 2025).

  2. [2]
    Medtronic begins full launch of MiniMed 780G with Abbott Instinct · Science journalism · 2025-12-02 — Full US commercial launch of the MiniMed 780G with Instinct on 2 Dec 2025, after ordering opened in September 2025.

    Drug Delivery Business. Medtronic begins full launch of MiniMed 780G with Abbott Instinct (Dec 2, 2025).

  3. [3]
    Medtronic Diabetes announces FDA clearance for MiniMed Go Smart MDI system featuring Instinct sensor made by Abbott · Manufacturer · 2026-01-12 — FDA clearance (12 Jan 2026) of MiniMed Go — the InPen smart pen plus the Instinct sensor in one app. Cleared for ages 7+, and 2–6 with adult supervision, for insulin-requiring type 1 and type 2 diabetes. US launch signalled for spring 2026.

    Medtronic Diabetes. Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott (Jan 12, 2026).

  4. [4]
    MiniMed expands sensor portfolio in Europe with CE Mark for MiniMed 780G system with the Instinct sensor, made by Abbott · Manufacturer · 2026-03-10 — CE Mark on 10 Mar 2026. EU indication is ages 2+ for type 1 and insulin-requiring type 2 diabetes, and — unlike the US label — includes pregnancy. 15-day wear vs 7 days for Guardian 4 / Simplera Sync.

    MiniMed. MiniMed expands sensor portfolio in Europe with CE Mark for MiniMed™ 780G system with the Instinct sensor, made by Abbott (Mar 10, 2026).

  5. [5]
    MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes · Manufacturer · 2026-06-23 — European rollout of Instinct and Instinct Go from 23 June 2026. MiniMed states that a randomized crossover study in Diabetes Technology & Therapeutics found 780G glycemic outcomes "virtually identical" on Instinct vs Simplera Sync, and cites real-world data from >20,000 US 780G users. The peer-reviewed crossover publication is cited separately below.

    MiniMed. MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes (Jun 23, 2026).

  6. [6]
    Glycemic Concordance of Simplera Sync and Instinct Sensors in MiniMed 780G System Users — randomized crossover feasibility study · Peer-reviewed study · 2026-05-21 — Laron-Hirsh M, Barel S, Roy A, et al. Diabetes Technology & Therapeutics (online ahead of print). PMID 42165353; DOI 10.1177/15209156261449884. Twenty-three adults with T1D completed two six-week sensor periods: mean TIR was 80.6% with Simplera Sync and 79.1% with Instinct, meeting the prespecified noninferiority criterion. The study assessed 780G glycemic outcomes, not standalone sensor accuracy or MARD against a reference method, and included MiniMed-affiliated authors.

    Laron-Hirsh M, Barel S, Roy A, et al. Glycemic Concordance of Simplera Sync and Instinct Sensors in MiniMed 780G System Users: A Randomized Crossover Feasibility Study. Diabetes Technology & Therapeutics (online ahead of print, 21 May 2026). PMID 42165353. DOI 10.1177/15209156261449884.

  7. [7]
    Instinct Sensor — Consumer Guide · Science journalism — American Diabetes Association consumer guide listing for Instinct: MARD 8.2%, 15-day wear, 1-hour warm-up, no calibration, readings every 5 minutes.

    American Diabetes Association. Instinct Sensor — Consumer Guide (MARD 8.2%; 15-day wear; 1-hour warm-up; no calibration; readings every 5 minutes).

  8. [8]
    FDA Class II recall Z-2698-2026 — MiniMed 780G software 6.62 OUS with Instinct · Regulatory decision · 2026-07-08 — Open recall for 778 European-market 780G pumps. The identified fault is in pump software 6.62 when paired with Instinct; this is not a recall of the sensor itself. Affected pump users were told to update to 6.63.

    U.S. FDA. Class II Device Recall MiniMed 780G Insulin Pump, software version 6.62 OUS — Z-2698-2026 (initiated 27 May; posted 8 July; open and classified when updated 6 August 2026).

  9. [9]
  10. [10]
    Current US Instinct configurations: MiniMed780G, MiniMedGo and MiniMedFlex · Manufacturer — The 17 August 2026 MiniMed release confirms US Flex with Instinct shipping. Current 780G and Go product pages independently list those configurations: https://www.minimed.com/en-us/products/minimed-780g-insulin-pump-system and https://www.minimed.com/en-us/products/minimed-go-system . Read 17 September 2026. These sources do not establish compatibility with every other system or global availability.

    MiniMed. MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor (17 August 2026).

  11. [11]

    MiniMed. MiniMed to Showcase MiniMed Flex and MiniMed Go at the American Diabetes Association Scientific Sessions (27 May 2026; says the US Go launch occurred that week). https://news.minimed.com/2026-05-27-MiniMed-to-Showcase-MiniMed-Flex-TM-and-MiniMed-Go-TM-at-the-American-Diabetes-Association-Scientific-Sessions